Novo Nordisk presented data from the phase 3 ELLIPSE trial.at the Pediatric Endocrine Society (PES)/Pediatric Academic Societies Annual Meeting in Baltimore, MD. The ELLIPSE trial evaluated Victoza (liraglutide) in children and adolescents aged 10-17 with type 2...
Pediatric Drugs
Category
Price Watch: High Cost of Clinical Trials Under FDA Pediatric Exclusivity Program Reviewed
Net return cost mean ration 689%